Brief: Puma Biotechnology Q3 Adjusted EPS USD 0.18
02/11/2023 20:05
Nov 02 (Reuters) - Puma Biotechnology Q3 product revenue USD 51.6 million. * Q3 net income USD 5.8 million * Q3 operating income USD 8.6 million * Q3 pretax profit USD 6 million * Q3 EPS USD 0.12 * Q3 adjusted net income USD 8.3 million
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2